(Q51760055)
Statements
Safety, pharmacokinetics and pharmocodynamics of recombinant human porphobilinogen deaminase in healthy subjects and asymptomatic carriers of the acute intermittent porphyria gene who have increased porphyrin precursor excretion. (English)
1 reference
Eliane Sardh
1 reference
Lillan Rejkjaer
1 reference
Dan E H Andersson
1 reference
Pauline Harper
1 reference
1 January 2007
1 reference
46
1 reference
4
1 reference
335-349
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference